Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Umar Syed Insider Profile
4 Followers
Umar Syed, Senior Officer at Cynapsus Therapeutics, holds 475.44K shares in Cynapsus Therapeutics (Ticker: CYNA). Most recently, Umar Syed Bought $100,000 shares of Cynapsus Therapeutics on Mar 05, 2009 for an estimated value of 10.00K.
Umar Syed Cynapsus Therapeutics (CYNA)Senior Officer
Cynapsus Therapeutics (CYNA)
Senior Officer
Not Ranked
Umar Syed has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Umar Syed does not currently own shares as a corporate insider.
A breakdown of Umar Syed's holdings
Insider Roles
Umar Syed does not currently hold a role as a corporate insider.
Roles that Umar Syed holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Umar Syed
Umar Syed's Trading History
List of latest transactions for each holding click on a transaction to see Umar Syed's performance on stock
You May Also Like
Umar Syed insider profile FAQ
What is the percentage of profitable transactions made by Umar Syed?
The percentage of profitable transactions made by Umar Syed is ―.
What is the average return per transaction made by Umar Syed?
The average return per transaction made by Umar Syed is ―.
What stocks does Umar Syed hold?
Umar Syed holds: CYNA stocks.
What was Umar Syed’s latest transaction?
Umar Syed latest transaction was an Informative Buy of $10.00K.
What was Umar Syed's most profitable transaction?
Umar Syed’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Umar Syed's role in Cynapsus Therapeutics?
Umar Syed's role in Cynapsus Therapeutics is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.